He-Wei Jiang
Overview
Explore the profile of He-Wei Jiang including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
37
Citations
1651
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Chen H, He X, Jiang H, Zheng Y, Zhang H, Wu F, et al.
Acta Biochim Biophys Sin (Shanghai)
. 2024 Mar;
56(5):819-823.
PMID: 38545657
No abstract available.
2.
Jiang H, Chen H, Zheng Y, Wang X, Meng Q, Xie J, et al.
Sci China Life Sci
. 2023 Apr;
66(8):1869-1887.
PMID: 37059927
Protein-biomolecule interactions play pivotal roles in almost all biological processes. For a biomolecule of interest, the identification of the interacting protein(s) is essential. For this need, although many assays are...
3.
Jiang H, Li Y, Tao S
Cell Mol Immunol
. 2023 Mar;
20(5):540-542.
PMID: 36973483
No abstract available.
4.
Wang X, Sim B, Chen H, Zheng Y, Xue J, Wang L, et al.
Acta Biochim Biophys Sin (Shanghai)
. 2022 Oct;
54(10):1453-1463.
PMID: 36239351
Type 2 diabetes mellitus (T2DM) is recognized as a serious public health concern with increasing incidence. The dipeptidyl peptidase-4 (DPP-4) inhibitor sitagliptin has been used for the treatment of T2DM...
5.
Lai D, Xue J, He P, Jiang H, Li Y, Ma M, et al.
Proteomics
. 2022 Oct;
23(2):e2200306.
PMID: 36205637
The majority of people in China have been immunized with the inactivated viral vaccine BBIBP-CorV. The emergence of the Omicron variant raised the concerns about protection efficacy of the inactivated...
6.
Ou F, Lai D, Kuang X, He P, Li Y, Jiang H, et al.
Biosens Bioelectron
. 2022 Sep;
217:114710.
PMID: 36174360
COVID-19 is still unfolding, while many people have been vaccinated. In comparison to nucleic acid testing (NAT), antibody-based immunoassays are faster and more convenient. However, its application has been hampered...
7.
Lai D, Jiang H, Li Y, Zhang H, Tao S
STAR Protoc
. 2022 Mar;
3(2):101238.
PMID: 35310073
The immunogenicity of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) proteome is largely unknown. Here we describe a protocol for analyzing sera samples with SARS-CoV-2 proteome microarray. The proteins were...
8.
Xue J, Lai D, Jiang H, Qi H, Guo S, Zhu Y, et al.
Cell Discov
. 2022 Feb;
8(1):15.
PMID: 35169145
No abstract available.
9.
Lei Q, Yu C, Li Y, Hou H, Xu Z, Yao Z, et al.
J Adv Res
. 2022 Feb;
36:133-145.
PMID: 35116173
Introduction: The COVID-19 global pandemic is far from ending. There is an urgent need to identify applicable biomarkers for early predicting the outcome of COVID-19. Growing evidences have revealed that...
10.